The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
Crossref DOI link: https://doi.org/10.1007/s00259-017-3649-9
Published Online: 2017-02-16
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verburg, Frederik A. http://orcid.org/0000-0002-7161-0979
,
Luster, Markus
Giovanella, Luca
Lassmann, Michael
Chiesa, Carlo
Chouin, Nicolas
Flux, Glenn
License valid from 2017-02-16